JD Supra9d
COVID-19 Vaccine Patent War: Moderna's Claims Invalidated by PTAB
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
pharmaphorum2d
The critical bioanalytical strategies unlocking the potential of LNP-mRNA
Lipid nanoparticle (LNP ... and high sensitivity is preferred for clinical diagnostic studies. Moderna’s SpikeVax vaccine is based on LNP-encapsulated nucleoside-modified mRNA encoding the ...
Nasdaq16d
Genevant Sciences and Arbutus Biopharma File International Lawsuits Against Moderna for Patent Infringement of Lipid Nanoparticle Technology
Genevant Sciences and Arbutus Biopharma have filed five international lawsuits against Moderna Inc. to enforce patents related to their lipid nanoparticle (LNP) technology, which is used in ...
FiercePharma15d
Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits
The companies specifically claim that Moderna uses their patented lipid nanoparticle (LNP) delivery technology, which is key to ensuring mRNA doesn’t degrade in the body, in its COVID-19 vaccine ...
Yahoo Finance16d
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid ... innovative LNP technology against Moderna, Inc ...